These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17398260)

  • 1. Botulinum toxin type A and other factors.
    Dai AI
    Arch Phys Med Rehabil; 2007 Apr; 88(4):541-2; author reply 542. PubMed ID: 17398260
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of intramuscular botulinum toxin in Malaysian children with cerebral palsy.
    Khoo TB; Yusniza MY; Chern PM
    Med J Malaysia; 2007 Mar; 62(1):3-5. PubMed ID: 17682560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin: does the black box warning justify change in practice?
    Narayanan UG
    Dev Med Child Neurol; 2011 Feb; 53(2):101-2. PubMed ID: 21244406
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacologic management of spasticity in cerebral palsy.
    Mooney JF; Koman LA; Smith BP
    J Pediatr Orthop; 2003; 23(5):679-86. PubMed ID: 12960637
    [No Abstract]   [Full Text] [Related]  

  • 5. Botulinum toxin A injection for children with spastic cerebral palsy.
    YaJie W; BaoQin G
    Dev Med Child Neurol; 2008 Aug; 50(8):640. PubMed ID: 18754907
    [No Abstract]   [Full Text] [Related]  

  • 6. Parental evaluation and botulinum toxin type A.
    Dai AI
    Arch Phys Med Rehabil; 2007 Apr; 88(4):541; author reply 541. PubMed ID: 17398261
    [No Abstract]   [Full Text] [Related]  

  • 7. European consensus table 2006 on botulinum toxin for children with cerebral palsy.
    Heinen F; Molenaers G; Fairhurst C; Carr LJ; Desloovere K; Chaleat Valayer E; Morel E; Papavassiliou AS; Tedroff K; Ignacio Pascual-Pascual S; Bernert G; Berweck S; Di Rosa G; Kolanowski E; Krägeloh-Mann I
    Eur J Paediatr Neurol; 2006; 10(5-6):215-25. PubMed ID: 17097905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When it comes to botulinum toxin, children and adults are not the same: multimuscle option for children with cerebral palsy.
    Heinen F; Schroeder AS; Fietzek U; Berweck S
    Mov Disord; 2006 Nov; 21(11):2029-30. PubMed ID: 16972275
    [No Abstract]   [Full Text] [Related]  

  • 9. Sonography-guided injection of botulinum toxin in children with cerebral palsy.
    Berweck S; Schroeder AS; Fietzek UM; Heinen F
    Lancet; 2004 Jan; 363(9404):249-50. PubMed ID: 14738817
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse events and health status following botulinum toxin type A injections in children with cerebral palsy.
    O'Flaherty SJ; Janakan V; Morrow AM; Scheinberg AM; Waugh MC
    Dev Med Child Neurol; 2011 Feb; 53(2):125-30. PubMed ID: 21244412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy.
    Gibson N; Graham HK; Love S
    Disabil Rehabil; 2007 Dec; 29(23):1813-22. PubMed ID: 18033606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the treatments for the cerebral palsy child].
    Bérard C; de Lattre C
    Arch Pediatr; 2006 Jun; 13(6):617-20. PubMed ID: 16713208
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE; Racette BA
    Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu ; Tiebin Yan ; Jianning Mai
    Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Upper extremity botulinum toxin treatment in cerebral palsy. Treatment guidelines the first step towards national cooperation].
    Arner M; Himmelmann K; Pontén E; Stankovic N; Hansson T; Dahlin LB
    Lakartidningen; 2008 Oct 22-28; 105(43):3009-13. PubMed ID: 19024613
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence-based review of safety and efficacy in cerebral palsy.
    Tilton AH
    Toxicon; 2015 Dec; 107(Pt A):105-8. PubMed ID: 26403867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin in cerebral child palsy.
    Ianieri G; Saggini R; Marvulli R; Tondi G; Aprile A; Ranieri M; Di Teo L; Altini S; Lancioni GE; Goffredo L; Megna M; Megna G
    Int J Immunopathol Pharmacol; 2009; 22(3 Suppl):9-11. PubMed ID: 19887036
    [No Abstract]   [Full Text] [Related]  

  • 18. 'Effectiveness of sedation using nitrous oxide compared with enteral midazolam for botulinum toxin A injections in children'.
    Gubbay A; Langdon K
    Dev Med Child Neurol; 2009 Jun; 51(6):491-2; author reply 492. PubMed ID: 19416317
    [No Abstract]   [Full Text] [Related]  

  • 19. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
    Dai AI; Wasay M; Awan S
    J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does botulinum toxin prevent or promote deformity in children with cerebral palsy?
    Gough M
    Dev Med Child Neurol; 2009 Feb; 51(2):89-90. PubMed ID: 19191839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.